The encouraging results from the first clinical study examining the effects of hemp-based cannabidiol on arthritic dogs were published in @FrontVetScience earlier this year.
Click to read more from @Leafly
https://t.co/Q4dxRmUcX8…
Studies show Type I & II (CB1 and CB2) receptors are not the only receptors that cannabinoids target. Read on for an in depth look at how the target, GPR55 has emerged as a major contributor to cannabis' actions in the brain and body from @Leafly.
https://t.co/kSQe4xcJld…
According to cannabis research firm @BDSAnalytics, the number of extract products with non-psychoactive CBD grew by nearly 171 percent last year.
https://t.co/eMCpYTQRPl